The upregulation of c-Myb in our inducible model is approximately 1.5- to 2-fold in vitro, depending on the cell line, which corresponds to dysregulated expression observed in patients with acute lymphoblastic leukemia or colorectal cancer (33, 34). Here, MYB is linked to acute lymphoblastic leukemia.